(XPOF) Xponential Fitness - Overview
Sector: Consumer Cyclical | Industry: Leisure | Exchange: NYSE (USA) | Market Cap: 280m USD | Total Return: -40.7% in 12m
Avg Turnover: 3.38M
Qual. Beats: 0
Rev. Trend: 21.4%
Qual. Beats: -1
Warnings
Negative Equity with losses - insolvent profile
High Debt/EBITDA (6.6) with thin interest coverage (1.3)
High Debt while negative Cash Flow
Altman Z'' -7.97 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Xponential Fitness, Inc. (XPOF) is a franchisor of boutique fitness brands headquartered in Irvine, California. Its portfolio includes diverse fitness modalities such as Club Pilates, StretchLab, YogaSix, Pure Barre, and BFT. The company operates within the leisure facilities sub-industry, focusing on specialized, instructor-led group workouts rather than traditional big-box gym models.
The business model relies on a capital-light franchise structure, where recurring revenue is generated through royalty fees and equipment sales to third-party operators. Boutique fitness typically commands higher price points per session compared to general fitness centers, targeting a specific consumer demographic willing to pay for specialized programming. For a deeper look into the companys financial health, consider reviewing the fundamental metrics available on ValueRay.
Founded in 2017 and listed on the NYSE in 2021, Xponential Fitness currently operates as a micro-cap entity within the consumer discretionary sector. The companys growth strategy centers on domestic and international franchise expansion across its multi-brand platform.
- Franchise system-wide sales growth drives royalty and marketing fund revenue
- New studio openings and North American footprint expansion scale margins
- Consumer discretionary spending shifts impact membership retention and studio traffic
- Corporate restructuring and capital allocation strategy influences investor confidence
| Net Income: -33.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -3.12 > 1.0 |
| NWC/Revenue: -9.36% < 20% (prev -7.16%; Δ -2.19% < -1%) |
| CFO/TA 0.00 > 3% & CFO 811k > Net Income -33.2m |
| Net Debt (518.9m) to EBITDA (79.0m): 6.57 < 3 |
| Current Ratio: 0.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.3m) vs 12m ago 10.05% < -2% |
| Gross Margin: 79.92% > 18% (prev 0.66%; Δ 7.93k% > 0.5%) |
| Asset Turnover: 81.30% > 50% (prev 77.12%; Δ 4.17% > 0%) |
| Interest Coverage Ratio: 1.29 > 6 (EBITDA TTM 79.0m / Interest Expense TTM 52.3m) |
| A: -0.09 (Total Current Assets 71.1m - Total Current Liabilities 99.0m) / Total Assets 322.4m |
| B: -2.30 (Retained Earnings -741.2m / Total Assets 322.4m) |
| C: 0.18 (EBIT TTM 67.6m / Avg Total Assets 367.4m) |
| D: -1.09 (Book Value of Equity -758.3m / Total Liabilities 694.4m) |
| Altman-Z'' = -7.97 = D |
| DSRI: 1.10 (Receivables 38.3m/36.9m, Revenue 298.7m/318.1m) |
| GMI: 0.82 (GM 79.92% / 65.92%) |
| AQI: 1.06 (AQ_t 0.71 / AQ_t-1 0.67) |
| SGI: 0.94 (Revenue 298.7m / 318.1m) |
| TATA: -0.11 (NI -33.2m - CFO 811k) / TA 322.4m) |
| Beneish M = -3.22 (Cap -4..+1) = AA |
As of May 30, 2026, the stock is trading at USD 5.49 with a total of 663,570 shares traded.
Over the past week, the price has changed by -1.61%,
over one month by -13.54%,
over three months by +28.87% and
over the past year by -40.71%.
Xponential Fitness has received a consensus analysts rating of 3.78. Therefore, it is recommended to hold XPOF.
- StrongBuy: 3
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 7.1 | 28.6% |
P/E Forward = 22.8311
P/S = 0.9387
P/B = 430.1984
Revenue TTM = 298.7m USD
EBIT TTM = 67.6m USD
EBITDA TTM = 79.0m USD
Long Term Debt = 500.0m USD (from longTermDebt, last quarter)
Short Term Debt = 9.72m USD (from shortTermDebt, last quarter)
Debt = 540.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 17.6m
Net Debt = 518.9m USD (calculated: Debt 540.4m - CCE 21.5m)
Enterprise Value = 799.3m USD (280.4m + Debt 540.4m - CCE 21.5m)
Interest Coverage Ratio = 1.29 (Ebit TTM 67.6m / Interest Expense TTM 52.3m)
EV/FCF = -250.6x (Enterprise Value 799.3m / FCF TTM -3.19m)
FCF Yield = -0.40% (FCF TTM -3.19m / Enterprise Value 799.3m)
FCF Margin = -1.07% (FCF TTM -3.19m / Revenue TTM 298.7m)
Net Margin = -11.10% (Net Income TTM -33.2m / Revenue TTM 298.7m)
Gross Margin = 79.92% ((Revenue TTM 298.7m - Cost of Revenue TTM 60.0m) / Revenue TTM)
Gross Margin QoQ = 84.94% (prev 76.68%)
Tobins Q-Ratio = 2.48 (Enterprise Value 799.3m / Total Assets 322.4m)
Interest Expense / Debt = 9.68% (Interest Expense 52.3m / Debt 540.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = 53.4m (EBIT 67.6m * (1 - 21.00%))
Current Ratio = 0.72 (Total Current Assets 71.1m / Total Current Liabilities 99.0m)
Debt / Equity = -1.71 (negative equity) (Debt 540.4m / totalStockholderEquity, last quarter -316.3m)
Debt / EBITDA = 6.57 (Net Debt 518.9m / EBITDA 79.0m)
Debt / FCF = -162.7 (out of range, set to none) (Net Debt 518.9m / FCF TTM -3.19m)
Total Stockholder Equity = -231.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -9.03% (Net Income -33.2m / Total Assets 322.4m)
RoE = -6.50% (Net Income TTM -33.2m / Total Stockholder Equity 510.3m)
RoCE = 6.70% (EBIT 67.6m / Capital Employed (Equity 510.3m + L.T.Debt 500.0m))
RoIC = 25.25% (NOPAT 53.4m / Invested Capital 211.6m)
WACC = 9.09% (E(280.4m)/V(820.8m) * Re(11.87%) + D(540.4m)/V(820.8m) * Rd(9.68%) * (1-Tc(0.21)))
Discount Rate = 11.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.56 | Cagr: -1.79%
[DCF] Fair Price = unknown (Cash Flow -3.19m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.58 | # QB: 0
Revenue Correlation: 21.42 | Revenue CAGR: 1.04% | SUE: -0.92 | # QB: -1
EPS current Quarter (2026-06-30): EPS=0.10 | Chg30d=-45.12% | Revisions=-43% | Analysts=5
EPS next Quarter (2026-09-30): EPS=0.17 | Chg30d=-17.58% | Revisions=+11% | Analysts=5
EPS current Year (2026-12-31): EPS=0.44 | Chg30d=-39.60% | Revisions=-50% | GrowthEPS=+189.8% | GrowthRev=-16.2%
EPS next Year (2027-12-31): EPS=0.76 | Chg30d=-15.56% | Revisions=-50% | GrowthEPS=+73.0% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: -50%